Delivery Order SPE2DB22D1202-SPE2DB25FVGP4
- Not listed
- The Defense Logistics Agency awarded a $1,454.70 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ketorolac 30 mg/mL vials. This is a firm fixed-price contract with no set-aside designation, reflecting competitive procurement on open terms. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency (DLA) awarded a $1,998.51 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials on May 12, 2025, with completion targeted for May 13, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.76 to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used for pain management across military and federal healthcare systems....
- The Defense Logistics Agency awarded a $3,865.76 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Ketorolac 30 mg/mL vials. This is a firm fixed-price, competitive award with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The delivery order is scheduled for completion by June 4, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials with a ceiling value of $2,144.62 under a firm fixed-price contract awarded on August 21, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's broader relationship with the federal government's medical procurement systems. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $2,424.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials. This delivery order was issued without a set-aside designation, indicating open competition, and carries an ultimate completion date of July 7, 2025. The award was issued on July 3, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ketorolac 30 mg/ml vials with a ceiling value of $1,382.72. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This award represents...
- The Defense Logistics Agency awarded a delivery order valued at $3,886.39 to AmerisourceBergen Drug Corp for the supply of Ketorolac 60 mg/2 mL vials on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used in military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,241.06 to AmerisourceBergen Drug Corp for Ketorolac 60 mg/2 mL vials on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed-price contract, classified as a non-set-aside award, represents a competitive procurement of pharmaceutical pain management medication to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGP4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,058.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials on August 6, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Ketorolac, a nonsteroidal anti-inflammatory pain management pharmaceutical, falls within the scope of medications covered under this pharmaceutical prime vendor agreement, which supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/6/25 |